fashion -WSS

fashion

author：explore 2025-10-02 00:52:37 - browse：9

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter:

In December, Vertex Pharmaceuticalsannounced results from a mid-stage clinical trial showing its experimental, non-opioid drug reduced pain in people with diabetes who have chronic pain. This quarter, the company will read out results from Phase 3 studies of the same pain drug, called VX-548, in people with acute pain following surgery.

The next big test of Alnylam Pharmaceuticals’pipeline of RNA-interference medicines looms with the outcome of a Phase 3 study called HELIOS-B that is investigating vutrisiran as a treatment for ATTR-CM, a progressive disease that leads to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Patients' immediate access to test results puts radiologists in a bind

hotspot

WSS

Hilary may become 1st tropical storm to make landfall in California in 84 years

What PEPFAR has meant on the ground in Ukraine

Roche to buy Carmot Therapeutics, developer of obesity drugs

What causes an itch? Researchers may have solved the mystery

AI models in health care face new federal disclosure requirements

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

focus

fashion

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

ProMED sees offers of support, but its future remains unclear

Guidelines to prevent youth baseball injuries need more muscle

Supreme Court wrestles with OxyContin maker's bankruptcy deal

How one medical school became remarkably diverse

AI models in health care face new federal disclosure requirements

Medicare proposal to cover medical devices draws a mixed reaction

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Tori Bowie and the unacceptable rates of Black maternal death

Evacuations in place as 3 wildfires burn in eastern Washington state

knowledge

ProMED sees offers of support, but its future remains unclear

Pharma patents targeted by Biden in move to slash drug prices

New definition of a human embryo proposed amid rapid advances

New details revealed about Purdue's marketing of OxyContin

Why sickle cell disease is getting the first CRISPR treatment

Evacuations in place as 3 wildfires burn in eastern Washington state

entertainment

hotspot

hotspot

focus